Company profile for Trellis Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Trellis Bioscience is a clinical-stage biotech company using its CellSpot? platform to discover rare, naturally optimized antibodies from healthy donor blood. Backed by NIH grants and venture capital, and led by an ex-pharma, serial entrepreneur team, Trellis develops candidates with minimal off-target toxicity. Its pipeline includes antibodies targeting drug-resistant bacteria, RSV, HCMV, and a pan-influenza cocktail?each sho...
Trellis Bioscience is a clinical-stage biotech company using its CellSpot? platform to discover rare, naturally optimized antibodies from healthy donor blood. Backed by NIH grants and venture capital, and led by an ex-pharma, serial entrepreneur team, Trellis develops candidates with minimal off-target toxicity. Its pipeline includes antibodies targeting drug-resistant bacteria, RSV, HCMV, and a pan-influenza cocktail?each showing strong preclinical efficacy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
702 Marshall Street Suite 301 Redwood City, CA 94063
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty